(1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine

C105H209F6N19O2 — CID 159731922

IUPAC(1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine
SMILESC[C@@H]1C(CN2CCNCC2)[C@@]2(C)C[C@H]2N1C(C)(C)C.C[C@@H]1CC2(CN)CC2N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN(C)C)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN2CCOCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@H](CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@H](CN2CCOCC2)N1C(C)(C)C
InChIInChI=1S/C16H31N3.2C14H28FN3.2C14H27FN2O.C12H25FN2.C11H22N2.C10H21FN2/c1-12-13(11-18-8-6-17-7-9-18)16(5)10-14(16)19(12)15(2,3)4;2*1-11-9-12(15)13(18(11)14(2,3)4)10-17-7-5-16-6-8-17;2*1-11-9-12(15)13(17(11)14(2,3)4)10-16-5-7-18-8-6-16;1-9-7-10(13)11(8-14(5)6)15(9)12(2,3)4;1-8-5-11(7-12)6-9(11)13(8)10(2,3)4;1-7-5-8(11)9(6-12)13(7)10(2,3)4/h12-14,17H,6-11H2,1-5H3;2*11-13,16H,5-10H2,1-4H3;2*11-13H,5-10H2,1-4H3;9-11H,7-8H2,1-6H3;8-9H,5-7,12H2,1-4H3;7-9H,5-6,12H2,1-4H3/t12-,13?,14-,16-;11-,12-,13+;11-,12-,13-;11-,12-,13+;11-,12-,13-;9-,10-,11-;8-,9?,11?;7-,8-,9-/m11111111/s1
InChIKeyNBIMFPASNWFYIP-OOSOWHIYSA-N
MW1883.95 g/mol
LogP13.90
Rot. Bonds14

About (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine

(1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine (PubChem CID 159731922) has the molecular formula C105H209F6N19O2 and a molecular weight of 1883.95 g/mol. Its IUPAC name is (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine.

Molecular Properties

Compound Name(1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine
PubChem CID159731922
Molecular FormulaC105H209F6N19O2
Molecular Weight1883.95 g/mol
Exact Mass1882.67
IUPAC Name(1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine
SMILESC[C@@H]1C(CN2CCNCC2)[C@@]2(C)C[C@H]2N1C(C)(C)C.C[C@@H]1CC2(CN)CC2N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN(C)C)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN2CCOCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@H](CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@H](CN2CCOCC2)N1C(C)(C)C
InChIInChI=1S/C16H31N3.2C14H28FN3.2C14H27FN2O.C12H25FN2.C11H22N2.C10H21FN2/c1-12-13(11-18-8-6-17-7-9-18)16(5)10-14(16)19(12)15(2,3)4;2*1-11-9-12(15)13(18(11)14(2,3)4)10-17-7-5-16-6-8-17;2*1-11-9-12(15)13(17(11)14(2,3)4)10-16-5-7-18-8-6-16;1-9-7-10(13)11(8-14(5)6)15(9)12(2,3)4;1-8-5-11(7-12)6-9(11)13(8)10(2,3)4;1-7-5-8(11)9(6-12)13(7)10(2,3)4/h12-14,17H,6-11H2,1-5H3;2*11-13,16H,5-10H2,1-4H3;2*11-13H,5-10H2,1-4H3;9-11H,7-8H2,1-6H3;8-9H,5-7,12H2,1-4H3;7-9H,5-6,12H2,1-4H3/t12-,13?,14-,16-;11-,12-,13+;11-,12-,13-;11-,12-,13+;11-,12-,13-;9-,10-,11-;8-,9?,11?;7-,8-,9-/m11111111/s1
InChIKeyNBIMFPASNWFYIP-OOSOWHIYSA-N
XLogP13.90
TPSA151.95 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds14
Heavy Atoms132
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001883.95
LogP ≤ 513.90
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Analyze (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine?
The IUPAC name of (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine (CID 159731922) is (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine.
What is the SMILES notation for (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine?
The canonical SMILES for (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine is C[C@@H]1C(CN2CCNCC2)[C@@]2(C)C[C@H]2N1C(C)(C)C.C[C@@H]1CC2(CN)CC2N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN(C)C)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@@H](CN2CCOCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@H](CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)[C@H](CN2CCOCC2)N1C(C)(C)C.
What is the InChIKey of (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine?
The InChIKey is NBIMFPASNWFYIP-OOSOWHIYSA-N. The full InChI is InChI=1S/C16H31N3.2C14H28FN3.2C14H27FN2O.C12H25FN2.C11H22N2.C10H21FN2/c1-12-13(11-18-8-6-17-7-9-18)16(5)10-14(16)19(12)15(2,3)4;2*1-11-9-12(15)13(18(11)14(2,3)4)10-17-7-5-16-6-8-17;2*1-11-9-12(15)13(17(11)14(2,3)4)10-16-5-7-18-8-6-16;1-9-7-10(13)11(8-14(5)6)15(9)12(2,3)4;1-8-5-11(7-12)6-9(11)13(8)10(2,3)4;1-7-5-8(11)9(6-12)13(7)10(2,3)4/h12-14,17H,6-11H2,1-5H3;2*11-13,16H,5-10H2,1-4H3;2*11-13H,5-10H2,1-4H3;9-11H,7-8H2,1-6H3;8-9H,5-7,12H2,1-4H3;7-9H,5-6,12H2,1-4H3/t12-,13?,14-,16-;11-,12-,13+;11-,12-,13-;11-,12-,13+;11-,12-,13-;9-,10-,11-;8-,9?,11?;7-,8-,9-/m11111111/s1.
What are the key properties of (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine?
(1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine has a molecular weight of 1883.95 g/mol, XLogP of 13.90, 14 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,3R,5R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]-N,N-dimethylmethanamine;[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methanamine;4-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;4-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(2R,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[[(2S,3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methanamine is sourced from PubChem (CID 159731922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).